Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
ICCC
— ImmuCell Corporation
NASDAQ
FULL STOCK PAGE →
Q1 2026 Earnings Call Summary
MAY 15, 2026
REVENUE
$10.4M
+35.8%
NET MARGIN
18.7%
+56.1 PTS
EPS
$0.21
+167.7%
FREE CASH FLOW
$3.4M
+994.6%
No summary has been written for this call yet.
← NEWER CALL
CALL 2 OF 4
OLDER CALL →